| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0015 | 1 |